Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-de-dimethylaminotetracycline
2. 4-dedimethylaminotetracycline
3. 4-des-dimethylaminotetracycline
4. Cmt-1
1. Cmt-1
2. 4-dedimethylaminotetracycline
3. 2444-65-7
4. Chembl3622800
5. 4-des-dimethylaminotetracycline
6. 4-de-dimethylaminotetracycline
7. 4-de(dimethylamino)tetracycline
8. Schembl2614027
9. Bdbm170149
10. Zinc4879584
11. Bdbm50124122
12. (4as,5as,6s,12ar)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
13. 2-naphthacenecarboxamide, 1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4as-(4aalpha,5aalpha,6beta,12aalpha))-
| Molecular Weight | 401.4 g/mol |
|---|---|
| Molecular Formula | C20H19NO8 |
| XLogP3 | 0.1 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 1 |
| Exact Mass | 401.11106656 g/mol |
| Monoisotopic Mass | 401.11106656 g/mol |
| Topological Polar Surface Area | 178 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 891 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Matrix Metalloproteinase Inhibitors
Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. (See all compounds classified as Matrix Metalloproteinase Inhibitors.)
ABOUT THIS PAGE
A 4-Des-Dimethylaminotetracycline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4-Des-Dimethylaminotetracycline, including repackagers and relabelers. The FDA regulates 4-Des-Dimethylaminotetracycline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4-Des-Dimethylaminotetracycline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 4-Des-Dimethylaminotetracycline supplier is an individual or a company that provides 4-Des-Dimethylaminotetracycline active pharmaceutical ingredient (API) or 4-Des-Dimethylaminotetracycline finished formulations upon request. The 4-Des-Dimethylaminotetracycline suppliers may include 4-Des-Dimethylaminotetracycline API manufacturers, exporters, distributors and traders.
click here to find a list of 4-Des-Dimethylaminotetracycline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 4-Des-Dimethylaminotetracycline DMF (Drug Master File) is a document detailing the whole manufacturing process of 4-Des-Dimethylaminotetracycline active pharmaceutical ingredient (API) in detail. Different forms of 4-Des-Dimethylaminotetracycline DMFs exist exist since differing nations have different regulations, such as 4-Des-Dimethylaminotetracycline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 4-Des-Dimethylaminotetracycline DMF submitted to regulatory agencies in the US is known as a USDMF. 4-Des-Dimethylaminotetracycline USDMF includes data on 4-Des-Dimethylaminotetracycline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 4-Des-Dimethylaminotetracycline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 4-Des-Dimethylaminotetracycline suppliers with USDMF on PharmaCompass.
4-Des-Dimethylaminotetracycline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 4-Des-Dimethylaminotetracycline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 4-Des-Dimethylaminotetracycline GMP manufacturer or 4-Des-Dimethylaminotetracycline GMP API supplier for your needs.
A 4-Des-Dimethylaminotetracycline CoA (Certificate of Analysis) is a formal document that attests to 4-Des-Dimethylaminotetracycline's compliance with 4-Des-Dimethylaminotetracycline specifications and serves as a tool for batch-level quality control.
4-Des-Dimethylaminotetracycline CoA mostly includes findings from lab analyses of a specific batch. For each 4-Des-Dimethylaminotetracycline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
4-Des-Dimethylaminotetracycline may be tested according to a variety of international standards, such as European Pharmacopoeia (4-Des-Dimethylaminotetracycline EP), 4-Des-Dimethylaminotetracycline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (4-Des-Dimethylaminotetracycline USP).
LOOKING FOR A SUPPLIER?
